Biotin-PEG-maleimide (MW 2000) is a PEG derivative consisting of a linear PEG chain, with biotin attached to one end and maleimide modified on the other. The maleimide end anchors drugs or targeting ligands to liposomes or polymeric nanocarriers, while the biotin end facilitates in vitro purification or in vivo targeted release.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
